Skip to main content
. 2022 Sep 21;2022:9016296. doi: 10.1155/2022/9016296

Figure 2.

Figure 2

The biological regulation of IFNγ on different types of NSCLC cells. (a) Cell viability analysis by CCK assay in NSCLC cell lines treated with a dose gradient of IFNγ for 24 h. (b) Cell viability analysis by CCK assay in NSCLC cell lines treated with or without IFNγ/STAT3 inhibitor for 24 h. (c) The protein expression level of p-STAT1 detected by western blotting in H3255 treated with different concentrations of IFNγ (0, 10, 50, 100, 500 ng/ml).